Showing results (401-410 of 679) with videos related to
Sort By:
Pageof 68
Biomedical Mass Spectrometry|October 1, 1978
[OH]- negative chemical ionization mass spectrometry. Reactions of [OH]- with methadone, l-alpha-acetylmethadol and their metabolitesA L Smit, F H FieldBiomedical Mass Spectrometry|June 1, 1980
Mass spectrometry of the metabolites of 2-ethyl-2,3-dihydro-5-benzofuranylacetic acidA G Giumanini, C CasaliniBiomedical Mass Spectrometry|June 1, 1977
Limitations of diazomethane for the quantification of 15-oxo-prostaglandin F2alphaA F Cockerill, N J Gutteridge, D N Mallen, et al.Biomedical Mass Spectrometry|June 1, 1976
Gas chromatographic and mass spectrometric analysis of the products of methylation of sulfonylurea drugsK K Midha, D V Awang, I J McGilverayBiomedical Mass Spectrometry|December 1, 1976
A model for ionization mechanisms in field desorption mass spectrometryJ F Holland, B Soltmann, C C SweeleyBiomedical Mass Spectrometry|February 1, 1975
Plasma amino acid analysis by isotope ratio gas chromatography mass spectrometry computer techniquesM F Schulman, F P AbramsonBiomedical Mass Spectrometry|March 1, 1978
Mass spectrometry of medicines. Quantitative determination by direct probe inlet system mass chromatographyA Tatematsu, H Yoshizumi, T Nadai, et al.Biomedical Mass Spectrometry|August 1, 1977
Quinoxalinol derivatives of aliphatic 2-oxocarboxylic acids. Infrared and mass spectra of the O-trimethylsilylated compoundsU Langenbeck, H U Möhring, B Hinney, et al.Biomedical Mass Spectrometry|August 1, 1977
Mass spectrometric characterization of activated N-(2-chloroethyl)amino oxazaphosphorine derivativeM Przybylski, H Ringsdorf, U Lenssen, et al.Biomedical Mass Spectrometry|August 1, 1977
Mass spectrometric determination of new prostaglandin derivatives (series A and E)J Roselló, C Suñol, J M Tusell, et al.Pageof 68